O15111

PTMD Annotation Information


※ Protein Information

Tag Content
UniProt Accession IKKA_HUMAN; O15111;
Entrez ID 1147
GenBank Protein ID
GenBank Nucleotide ID
Protein Name Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor k
Gene Name CHUK; IKKA; TCF16
Organism Homo sapiens
NCBI Taxa ID 9606
Functional DescriptionSerine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses. Acts as part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B on serine residues. These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome. In turn, free NF-kappa-B is translocated into the nucleus and a(view all)
Sequence
(Fasta)
MERPPGLRPG AGGPWEMRER LGTGGFGNVC LYQHRELDLK IAIKSCRLEL STKNRERWCH 60
EIQIMKKLNH ANVVKACDVP EELNILIHDV PLLAMEYCSG GDLRKLLNKP ENCCGLKESQ 120
ILSLLSDIGS GIRYLHENKI IHRDLKPENI VLQDVGGKII HKIIDLGYAK DVDQGSLCTS 180
FVGTLQYLAP ELFENKPYTA TVDYWSFGTM VFECIAGYRP FLHHLQPFTW HEKIKKKDPK 240
CIFACEEMSG EVRFSSHLPQ PNSLCSLVVE PMENWLQLML NWDPQQRGGP VDLTLKQPRC 300
FVLMDHILNL KIVHILNMTS AKIISFLLPP DESLHSLQSR IERETGINTG SQELLSETGI 360
SLDPRKPASQ CVLDGVRGCD SYMVYLFDKS KTVYEGPFAS RSLSDCVNYI VQDSKIQLPI 420
IQLRKVWAEA VHYVSGLKED YSRLFQGQRA AMLSLLRYNA NLTKMKNTLI SASQQLKAKL 480
EFFHKSIQLD LERYSEQMTY GISSEKMLKA WKEMEEKAIH YAEVGVIGYL EDQIMSLHAE 540
IMELQKSPYG RRQGDLMESL EQRAIDLYKQ LKHRPSDHSY SDSTEMVKII VHTVQSQDRV 600
LKELFGHLSK LLGCKQKIID LLPKVEVALS NIKEADNTVM FMQGKRQKEI WHLLKIACTQ 660
SSARSLVGSS LEGAVTPQTS AWLPPTSAEH DHSLSCVVTP QDGETSAQMI EENLNCLGHL 720
STIIHEANEE QGNSMMNLDW SWLTE 746

※ PTM-Disease Association

NumPTMDiseaseCell TypeTypePTM SitePMID
1PhosphorylationEndotoxemiaP24698353
[Reference]: Endotoxemic mice exhibited higher muscle gene expression of components of the NF-B pathway, with the phosphorylation of IB kinase-/

※ Disease Cross-ref Annotation

DatabaseAnnotation
CTD (Curated)
(count: 7)
(view all)
MESH:D000015 ; Abnormalities, Multiple
MESH:D001848 ; Bone Diseases, Developmental
MESH:D002972 ; Cleft Palate
OMIM:613630 ; COCOON SYNDROME
MESH:D005315 ; Fetal Diseases
MESH:D017880 ; Limb Deformities, Congenital
DisGeNet (Curated)
(count: 20)
(view all)
C0005941; Bone Diseases, Developmental
C0008925; Cleft Palate
C0015929; Fetal Diseases
C0037268; Skin Abnormalities
C0206762; Limb Deformities, Congenital
C0241442; Protrusion of tongue
GWASdb
(count: 26)
(view all)
rs11597086; Type 2 diabetes; type 2 diabetes mellitus
rs11597086; Multiple complex diseases; Null
rs11597086; Cholesterol, total; coronary artery disease|lipid metabolism disorder|arteriosclerosis
rs11597086; Fatty liver disease; fatty liver disease
rs11597086; Alanine aminotransferase levels; fatty liver disease
rs11597086; Fatty liver and alanine aminotransferase (ALT) levels; fatty liver disease

※ PTM Sites

PTM Modification Sites
Phosphorylation
(count: 12)
(view all)
123       LKESQILSLLSDIGS     dbPAF
126       SQILSLLSDIGSGIR     dbPAF
168       HKIIDLGYAKDVDQG     dbPAF
176       AKDVDQGSLCTSFVG     dbPAF
179       VDQGSLCTSFVGTLQ     dbPAF
180       DQGSLCTSFVGTLQY     dbPAF
Acetylation
(count: 2)
569       QRAIDLYKQLKHRPS     PLMD
645       TVMFMQGKRQKEIWH     PLMD
Ubiquitination
(count: 12)
(view all)
105       CSGGDLRKLLNKPEN     PLMD
109       DLRKLLNKPENCCGL     PLMD
117       PENCCGLKESQILSL     PLMD
139       IRYLHENKIIHRDLK     PLMD
146       KIIHRDLKPENIVLQ     PLMD
158       VLQDVGGKIIHKIID     PLMD
Malonylation
(count: 1)
425       LPIIQLRKVWAEAVH     PLMD

※ Protein-Protein Interaction

NetworkInteraction
ABSource
F5GZ62O15111IntAct
F8VZJ4O15111MINT
H0YBT0O15111IntAct
O00221O15111DIP; IntAct; MINT
O14757O15111HPRD; MINT
O14920O15111HPRD; DIP; IntAct; MINT
O14965O15111DIP
O15111O15111HPRD; IntAct
O15111O43318HPRD; IntAct
O15111O43524HPRD
O15111O43734HPRD
O15111O75925HPRD
O15111O94832IntAct; MINT
O15111O95163HPRD
O15111O95999HPRD
O15111P03372HPRD
O15111P04350IntAct; MINT
O15111P04637HPRD
O15111P05771HPRD
O15111P06753IntAct; MINT
O15111P07437IntAct; MINT
O15111P07900HPRD; DIP; IntAct; MINT
O15111P08238HPRD; IntAct; MINT
O15111P12931HPRD; IntAct
O15111P15509HPRD
O15111P19105IntAct; MINT
O15111P19438HPRD
O15111P19525HPRD
O15111P19838DIP; MINT;HPRD
O15111P21580HPRD
O15111P25963HPRD; DIP; IntAct; MINT
O15111P30086HPRD
O15111P31749HPRD
O15111P31751HPRD
O15111P32121IntAct
O15111P35222HPRD
O15111P35568HPRD
O15111P35579IntAct; MINT
O15111P35580IntAct
O15111P36897HPRD
O15111P38646IntAct
O15111P41279HPRD
O15111P41743HPRD
O15111P49116HPRD
O15111P52907IntAct
O15111P60660IntAct; MINT
O15111P61353IntAct
O15111P62158IntAct; MINT
O15111P63261IntAct
O15111P78527HPRD
O15111P84022DIP
O15111Q00610IntAct
O15111Q00653HPRD; DIP; IntAct; MINT;MINT;IntAct
O15111Q01201IntAct; MINT
O15111Q04206HPRD; DIP; IntAct; MINT;IntAct
O15111Q04759HPRD
O15111Q05639IntAct
O15111Q06124HPRD
O15111Q06710IntAct
O15111Q12933HPRD
O15111Q13451HPRD; DIP; IntAct; MINT
O15111Q13616HPRD
O15111Q13748IntAct; MINT
O15111Q14790HPRD
O15111Q15653HPRD; DIP; IntAct; MINT
O15111Q15796DIP
O15111Q16543HPRD; DIP; IntAct; MINT
O15111Q16584HPRD
O15111Q16695HPRD
O15111Q4LE28HPRD
O15111Q7Z406IntAct; MINT
O15111Q7Z434IntAct
O15111Q86VP1IntAct
O15111Q86WI3IntAct
O15111Q8TEL6HPRD
O15111Q92793IntAct; MINT
O15111Q92844HPRD
O15111Q969T4HPRD
O15111Q96MN2HPRD
O15111Q96RR5DIP
O15111Q99558HPRD; DIP; IntAct; MINT
O15111Q99759IntAct; MINT
O15111Q9UGK3IntAct;HPRD
O15111Q9UM47HPRD; MINT
O15111Q9Y618HPRD
O15111Q9Y6K9HPRD; DIP; IntAct; MINT
O15111Q9Y6Q9HPRD; IntAct